Oral mucositis

JE Raber-Durlacher, S Elad, A Barasch - Oral oncology, 2010 - Elsevier
Mucosal damage is one of the most common adverse effects of radiotherapy and of cytotoxic
therapy for cancer. With prevalence between 10% and 100%, depending of the cytotoxic …

Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines

A Ariyawardana, KKF Cheng, A Kandwal, V Tilly… - Supportive Care in …, 2019 - Springer
Purpose The aim of this systematic review was to update the clinical practice guidelines for
the use of anti-inflammatory agents in the prevention and/or treatment of oral mucositis …

Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis

BY Hong, T Sobue, L Choquette, AK Dupuy… - Microbiome, 2019 - Springer
Background Gastrointestinal mucosal injury (mucositis), commonly affecting the oral cavity,
is a clinically significant yet incompletely understood complication of cancer chemotherapy …

Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy …

HS Antunes, D Herchenhorn, IA Small, CMM Araújo… - Oral oncology, 2017 - Elsevier
Background The impact of low-level laser therapy (LLLT) to prevent oral mucositis in
patients treated with exclusive chemoradiation therapy remains unknown. This study …

The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue

A Carlotto, VL Hogsett, EM Maiorini, JG Razulis… - …, 2013 - Springer
Side effects or toxicities are frequent, undesirable companions of almost all forms of non-
surgical cancer therapy. It is unusual for patients to complete treatment with radiation or …

Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation

HS Antunes, D Herchenhorn, IA Small… - Radiotherapy and …, 2013 - Elsevier
Background Oral mucositis (OM) is a complication of chemoradiotherapy treatment of head
and neck squamous cell carcinoma (HNSCC) patients with no effective therapy. This study …

Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life

J Deng, BA Murphy, MS Dietrich, N Wells… - Head & …, 2013 - Wiley Online Library
Background Lymphedema may disrupt local function and affect quality of life (QOL) in
patients with head and neck cancer. The purpose of this study was to examine the …

Burden of oral mucositis: a systematic review and implications for future research

K Berger, D Schopohl, A Bollig, D Strobach… - Oncology research and …, 2018 - karger.com
Background: Surprisingly little is known about the burden of oral mucositis (OM). We provide
a systematic review of studies on the burden of OM (incidence, economic impact, health …

Severe oral mucositis after intensity-modulated radiation therapy for head and neck cancer

AJ Iovoli, L Turecki, ML Qiu, M Khan, K Smith… - JAMA Network …, 2023 - jamanetwork.com
Importance Oral mucositis (OM) is a common and debilitating adverse effect observed in
patients with head and neck cancer (HNC) receiving radiation therapy (RT). Previous …

Clinical update: prevention and management of oral mucositis in patients with cancer

J Eilers, R Million - Seminars in oncology nursing, 2011 - Elsevier
OBJECTIVES: To present a clinical update of evidence that applies to the development of a
nursing plan of care for the prevention and treatment of oral mucositis related to cytotoxic …